Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tofacitinib for facial rosacea lesions
IRCT20251109067935N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tofacitinib in rosacea, sponsored by Tehran University of Medical Sciences. Started Dec 2025; status: recruiting.
02
Drugs
03
Conditions
rosacea
Beyond the preview
Go deeper on IRCT20251109067935N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251109067935N1.